Ionis Pharmaceuticals Inc
(NAS:IONS)
$
35.91
-0.42 (-1.16%)
Market Cap: 5.74 Bil
Enterprise Value: 4.73 Bil
PE Ratio: 0
PB Ratio: 8.65
GF Score: 40/100 Ionis Pharmaceuticals Inc at Stifel Healthcare Conference (Virtual) Transcript
Nov 15, 2021 / 03:40PM GMT
Release Date Price:
$32.79
(+0.31%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
Awesome. Thank you, Rob, and thanks to Eric Swayze, Executive Vice President of Research at Ionis Pharmaceuticals for joining us in front of a cool brain picture that we were just talking about. Thanks again. It's always fun to do a panel with you.
Questions & Answers
Paul Andrew Matteis;Eric E. Swayze
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst;Ionis Pharmaceuticals, Inc. - EVP of Research<
I think maybe just to set the stage, Eric, you guys hear this from investors all the time, right, there's a ton of pipeline products at Ionis. What are the kind of 2 to 3 things that you feel like are worth highlighting as we kick off that are either topical recently or maybe going to become more important or underappreciated over the next 12 months and then I can get into many of my questions, and we can go from there.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot